药物离子导入联合超短波治疗颈椎病源性心律失常疗效观察

Effect of Galvanoiontophoresis Combined with Ultrashort Wave Therapy on Cervical Vertebrae Disease-derived Arrhythmia

目的观察直流电药物离子导入联合超短波治疗颈椎病源性心律失常的疗效。方法112例颈椎病源性心律失常患者随机分为治疗组和对照组各56例,两组患者均服用抗心律失常药物、西比灵及活血祛瘀药物,治疗组在此基础上采用直流电药物离子导入,辅以超短波热疗消除无菌性炎症。结果治疗组治愈率51.8%、总有效率94.6%,对照组分别为16.1%和76.8%,治疗组均明显高于对照组(P<0.01)。结论直流电药物离子导入联合超短波综合疗法治疗颈椎病源性心律失常效果良好。

Objective To observe the curative effect of galvanoiontophoresis combined with ultrashort wave therapy on cervical vertebrae disease-derived arrhythmia. Methods 112 patients with cervical vertebrae disease-derived arrhythmia were randomly divided into the treatment group and control group with 56 cases in each group. All patients of two groups were treated with antiarrhythmia drug, Sibelium and traditional Chinese medicine. While, the patients of the treatment group were added with galvanoiontophoresis combined with ultrashort wave therapy to eliminate the aseptic inflammation. Results The cure rate and total effective rate of the treatment group were 51.8% and 94.6%. Those of the control group were 16. 1% and 76.8%. The effect of the treatment group was better than that of the control group significantly （ P〈0.01）. Conclusion The galvanoiontophoresis combined with ultrashort wave therapy has a better effect on cervical vertebrae disease-derived arrhythmia.